Fig. 6From: Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapyThe pathways enriched by hypomethylated and upregulated genes (fold change ≥1.5, p-value < 0.5)Back to article page